Invests primarily in equity securities of small-capitalization companies. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
Average growth of 6% a year over the last 4 years. Red columns mark years that ended in a loss.
This company is not turning a profit, so the market is pricing its sales instead: 138.7× for every dollar of annual revenue.
No analyst target is on record for this company.
The stock trades 37% below its peak. The market has trimmed its expectations for the company.
Sales run at $9.1M a year. A small number, but proof the product has real buyers.
It pays out $0.85 per share each year — regular cash for whoever holds the stock.
A loss of $121.2M against $9.1M in annual sales.
We grade companies — revenue, margins, balance sheets. This is a fund, so there is no report card to give. That is not a low grade; it is a different kind of thing.
One-line summary: a basket, not a business. Judge it by what it holds.